Rectal misoprostol versus oxytocin in the prevention of postpartum hemorrhage - A pilot study

International Journal of Gynecology and Obstetrics

Volumn 94, Issue SUPPL. 2, 2006, Pages

  Gupta, Babita ^a   Jain, Vanita ^a   Aggarwal, Neelam ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; MISOPROSTOL; OXYTOCIC AGENT; OXYTOCIN; PLACEBO; UTEROTONIC AGENT;

ARTICLE; BLEEDING; BLOOD SAMPLING; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INDIA; NAUSEA; PILOT STUDY; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SHIVERING; VAGINAL DELIVERY;

EID: 33845214328     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(06)60014-3     Document Type: Article

References (4)

1. Prendiville W., Elbourne D., and McDonald S. Active versus expectant management in the third stage of labor. Cochrane Database Syst Rev 3 (2000) CD000007
2. Khan R., and El-Refaey H. Pharmacokinetics and adverse effect profile of rectally administered misoprostol in the third stage of labour. Obstet Gynecol 101 (2003) 968-974
3. Gerstenfeld T., and Wing D. Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum haemorrhage after vaginal delivery. Am J Obstet Gynecol 185 (2001) 878-882
4. Patel A., Goudar S., Geller S., Kodkany B., Edlawitch S., Wagh K., et al. Drape estimation vs. visual assessment for estimating postpartum hemorrhage. Int J Gynaecol Obstet 93 (2006) 220-224